Support our Foundation of Myology project
1722 news items
Myology 2022: Institute of Myology experts will highlight their last scientific results
On 09/09/2022
During four days, from 12 to 15th of September, researchers and clinicians of the Institute of Myology will attend the seventh International Congress of Myology,…
REDs lab offers a post-doctoral position
On 06/09/2022
RNA metabolism and astrocyte dysfunction in myotonic dystrophy A two-year postdoctoral position is available from early 2023, in the laboratory Repeat Expansions and Myotonic Dystrophy,…
Diaphragm involvement in Pompe disease more clearly visualized on imaging
On 02/09/2022
The diaphragmatic muscle is a key muscle in Pompe disease, which causes its dysfunction due to a toxic accumulation of glycogen. Dutch researchers studied this…
Rituximab is proving to be an effective background treatment for MG, including in children
On 02/09/2022
Rituximab is an injectable monoclonal antibody that depletes B lymphocytes (CD20+); it is increasingly used in autoimmune diseases, including myasthenia. A Spanish study confirmed its…
MCR Seminar – 2 September – Ana Ferreiro
On 01/09/2022
Ana Ferreiro – Translational research in core myopathies : ‘from bedside to bench and back’ The Myology Center for Research (UMR974) is pleased to invite…
A novel method to treat recurrent pneumothorax in Ullrich myopathy
On 01/09/2022
American authors report the case of a 19-year-old patient suffering from Ullrich myopathy (collagen VI deficiency) since childhood and who presented a recurrent pneumothorax in…
ACTA1 gene-related nemaline myopathies: an international study to clarify phenotypes
On 31/08/2022
Pathological variants of the ACTA1 gene are responsible for half of the cases of nemaline myopathy (also known as rod myopathy). An international collaboration coordinated…
One in five adults with dermatomyositis discontinues immunomodulators at a median of three years
On 30/08/2022
In the United States, an expert center studied a cohort of 243 adults with dermatomyositis followed between 2013 and 2020 and treated with at least…
hiPSCs as a cellular model applicable to several LGMDs
On 29/08/2022
Researchers from the I-Stem and Genethon laboratories have explored the relevance of human induced pluripotent stem cells (hiPSC) for the cellular modeling of limb-girdle muscular…
The value of salbutamol in a form of CMS
On 29/08/2022
Clinicians report the case of an Egyptian brother and sister diagnosed with congenital myasthenic syndrome (CMS) linked to the gene encoding the acetylcholine receptor epsilon…
A new biomarker for autoimmune muscle rippling
On 26/08/2022
An American team retrospectively studied the clinical and biological data of ten patients with a non-genetic form of muscle rippling. Rippling is a spontaneous or…
What impact do swallowing disorders have on the survival of patients with inflammatory myopathy?
On 26/08/2022
Japanese clinicians studied dysphagia and other swallowing disorders in 254 patients with one of the forms of myositis (dermatomyositis, polymyositis, others), excluding inclusion myositis: a…
Save the date! 4th Neuromuscular Translational School, Nov. 21st-25th in Leiden, TheNetherlands
On 25/08/2022
The upcoming 4th Neuromuscular Translational School (under auspices of EURO-NMD and TREAT-NMD) will be held from November 21st- November 25th in Leiden (The Netherlands). Organized…
Publication of the results of the phase II trial of amifampridine in SMA
On 25/08/2022
An Italian phase II, randomised, crossover, placebo-controlled trial evaluated the safety and efficacy of amifampridine, a molecule that improves neuromuscular junction function, in 13 adults…
An atypical presentation of MELAS syndrome
On 25/08/2022
MELAS syndrome is classically presented as a mitochondrial encephalopathy complicated by lactic acidosis and recurrent strokes. However, this rare disease can have a more atypical…
Myositis is very often accompanied by the use of painkillers
On 25/08/2022
In the United States, 423 people with dermatomyositis (n=183), polymyositis (109) or inclusion myositis (131), most of which had been previously diagnosed one to five…
Asian mushroom supplements cause autoimmune necrotizing myopathy outbreak
On 24/08/2022
Rheumatologists from Baltimore (USA) report in the British Medical Journal the case of a thirty year old patient with autoimmune necrotizing myopathy with anti-HMGCR, with…
A new imaging tool to assess FSH
On 24/08/2022
Facioscapulohumeral muscular dystrophy (FSH) has recently entered the era of therapeutic trials with several innovative molecules in clinical development. An international consortium of researchers has…
A new tool for the follow-up of myasthenia gravis in teleconsultation
On 24/08/2022
The Covid-19 pandemic has boosted the use of video consultations and it is in this favourable context that a team of Italian neurologists has designed…
Batoclimab successfully completes Phase II in myasthenia gravis
On 23/08/2022
Anti-FcRn drugs facilitate the elimination of IgG, which includes the autoantibodies produced in myasthenia gravis. The first drug in this family, efgartigimod (Vyvgart®), was granted…
